Zecotek Announces 336nm DPSS Laser

Zecotek Introduces New Solid-State Laser for Mass Spectrometry

Vancouver, BC, June 11, 2008 – Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) today announced a new and proprietary solid-state 336nm DPSS laser designed to replace nitrogen gas lasers currently used in a wide range of mass spectrometry applications. Zecotek’s 336nm DPSS laser offers both superior performance and product lifetime characteristics as compared to existing lasers used in mass spectrometry based on the MALDI-TOF technique.

MALDI-TOF mass spectrometry is rapidly becoming the most widely used tool at the forefront of bio-molecular analysis. MALDI-TOF is also an important tool in quality control, due in part to its high throughput capabilities and ease of automation.

“We have an opportunity to meet the growing demand of MALDI-TOF laser systems,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “Our 336nm DPSS laser has been specifically designed to replace the cumbersome and shorter life span nitrogen gas lasers used in legacy systems. Zecotek is in the position to offer a major component to OEMs for their new generation MALDI-TOF systems. This is another excellent example of Zecotek’s strength in the innovation and development of leading edge photonic technologies.”

Zecotek’s new solid-state 336nm DPSS laser program is based in the Company’s Singapore laboratories and patent applications are in preparation. Under Zecotek’s joint manufacturing agreement, Fujikura Ltd. has first rights to manufacture the new device.

About Zecotek

Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing leading-edge products: crystals, photo detectors, lasers, imaging and 3D display technologies, for medical, biotech, industrial, nanotech and atomic/molecular science applications. Founded in 2003, the company has three distinct operating divisions: Laser Systems, Imaging Systems and 3D Display Systems and labs located in Canada, the United States, Singapore, Malaysia and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit Zecotek Photonics.

This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.

For product and technical information please contact:
Zecotek Photonics Inc., SUSANA MENDEZ ALCALA, SMA@zecotek.com, T: (604) 827-5232

For corporate information please contact:

Zecotek Photonics Inc., MICHAEL MINDER, CFO; VP Corporate Development, T: (604) 827-5203

For investor information please contact:
Caliber Capital & Communications, TIM MCNULTY, T: (778) 327-6678, E: ir@zecotek.com

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.